Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs
Authors
Keywords
-
Journal
RSC Advances
Volume 6, Issue 51, Pages 45553-45561
Publisher
Royal Society of Chemistry (RSC)
Online
2016-04-25
DOI
10.1039/c6ra03453e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ferucarbotran, a carboxydextran-coated superparamagnetic iron oxide nanoparticle, induces endosomal recycling, contributing to cellular and exosomal EGFR overexpression for cancer therapy
- (2015) Tsai-Hua Chung et al. RSC Advances
- Design Considerations of Iron-Based Nanoclusters for Noninvasive Tracking of Mesenchymal Stem Cell Homing
- (2014) Xinglu Huang et al. ACS Nano
- The pros and cons of chemokines in tumor immunology
- (2012) Antonella Viola et al. TRENDS IN IMMUNOLOGY
- Iron Oxide Nanoparticle-Induced Epidermal Growth Factor Receptor Expression in Human Stem Cells for Tumor Therapy
- (2011) Tsai-Hua Chung et al. ACS Nano
- In vivo magnetic resonance imaging of cell tropsim, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model
- (2011) Li-Ying Chien et al. BIOMATERIALS
- Potential implications of mesenchymal stem cells in cancer therapy
- (2011) Long-Jun Dai et al. CANCER LETTERS
- Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
- (2011) Xu-Yong Sun World Journal of Stem Cells
- CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
- (2010) S Singh et al. BRITISH JOURNAL OF CANCER
- Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment
- (2010) Shannon Kidd et al. CYTOTHERAPY
- Mesenchymal stem cells enhance growth and metastasis of colon cancer
- (2010) Kei Shinagawa et al. INTERNATIONAL JOURNAL OF CANCER
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
- (2010) Ann H. Klopp et al. STEM CELLS
- The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells
- (2010) Ying-Chun Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
- (2009) Erika L. Spaeth et al. PLoS One
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
- (2009) Shannon Kidd et al. STEM CELLS
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
- (2008) Ling Qiao et al. CELL RESEARCH
- Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells
- (2008) Berber D. Roorda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Migratory neighbors and distant invaders: tumor-associated niche cells
- (2008) J. Wels et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now